Trending...
- Sober.Buzz the Sober Token : Ticker $BUZZ
- Green Energy Solar Expands with New Offices in Port St. Lucie, West Palm Beach, and Orlando
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
MOGADORE, Ohio, May 17, 2024 ~ Omega Laboratories, a renowned drug testing laboratory, has announced a strategic partnership with Cannabix Technologies Inc., a pioneer in cannabis breathalyzer technology. This collaboration marks a significant milestone in the pursuit of innovative solutions for drug testing and safety assurance.
Cannabix Technologies Inc. is at the forefront of developing advanced breath analysis tools to accurately and non-invasively detect THC levels. Leveraging their expertise and cutting-edge technology, Omega Laboratories aims to revolutionize the landscape of drug testing by integrating Cannabix's THC breathalyzer into its suite of services.
The partnership between these two industry leaders will establish Omega as the exclusive provider of laboratory services for Cannabix's THC breathalyzer. With credible research and validation studies backing the effectiveness of this technology, Omega Laboratories is confident in its reliability and accuracy.
More on Ohio Pen
To further demonstrate the efficacy of the breathalyzer in real-world testing scenarios, Omega will be conducting a full validation study in collaboration with Cannabix. This study will ensure unparalleled accuracy and reliability for clients.
Rav Mlait, CEO of Cannabix Technologies Inc., expressed excitement about this partnership, stating that it solidifies their commitment to providing trusted and highly accredited solutions to clients.
The integration of Cannabix's THC breathalyzer technology into Omega Laboratories' testing protocols will enable rapid and precise detection of THC levels in breath samples. This innovative approach not only streamlines the testing process but also ensures reliable results for clients across various industries, including law enforcement, workplace safety, and healthcare.
As part of this collaboration, all breathalyzer samples analyzed by Omega Laboratories will undergo rigorous testing using mass spectrometry (mass spec), a gold standard in analytical chemistry. This meticulous approach reinforces Omega's commitment to delivering accurate and reliable results while maintaining the highest standards of quality and integrity.
More on Ohio Pen
With the rise in cannabis legalization, employers face new challenges when it comes to drug testing. Traditional methods such as oral fluid, urine, and hair tests can detect cannabis use for extended periods, ranging from days to months. However, utilizing the Cannabix breathalyzer allows for THC detection in just a few hours after use.
Bill Corl, CEO of Omega Laboratories, emphasized the company's commitment to staying at the forefront of advancements in drug testing technology. He believes that incorporating Cannabix's groundbreaking THC breathalyzer technology will enhance the accuracy, efficiency, and accessibility of cannabis testing.
This strategic partnership between Omega Laboratories and Cannabix Technologies is set to drive innovation and set new standards in cannabis testing, ensuring safer communities and workplaces. For more information on these solutions, interested parties can contact Omega at 1-800-665-5569.
Cannabix Technologies Inc. is at the forefront of developing advanced breath analysis tools to accurately and non-invasively detect THC levels. Leveraging their expertise and cutting-edge technology, Omega Laboratories aims to revolutionize the landscape of drug testing by integrating Cannabix's THC breathalyzer into its suite of services.
The partnership between these two industry leaders will establish Omega as the exclusive provider of laboratory services for Cannabix's THC breathalyzer. With credible research and validation studies backing the effectiveness of this technology, Omega Laboratories is confident in its reliability and accuracy.
More on Ohio Pen
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- Festo Features Multi-Axis Positioning Systems at Automate
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
To further demonstrate the efficacy of the breathalyzer in real-world testing scenarios, Omega will be conducting a full validation study in collaboration with Cannabix. This study will ensure unparalleled accuracy and reliability for clients.
Rav Mlait, CEO of Cannabix Technologies Inc., expressed excitement about this partnership, stating that it solidifies their commitment to providing trusted and highly accredited solutions to clients.
The integration of Cannabix's THC breathalyzer technology into Omega Laboratories' testing protocols will enable rapid and precise detection of THC levels in breath samples. This innovative approach not only streamlines the testing process but also ensures reliable results for clients across various industries, including law enforcement, workplace safety, and healthcare.
As part of this collaboration, all breathalyzer samples analyzed by Omega Laboratories will undergo rigorous testing using mass spectrometry (mass spec), a gold standard in analytical chemistry. This meticulous approach reinforces Omega's commitment to delivering accurate and reliable results while maintaining the highest standards of quality and integrity.
More on Ohio Pen
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- KRATON ANNOUNCES DECISION TO EXIT DOVER SITE TO FOCUS ON CORE BUSINESS GROWTH
- Goodyear Completes Sale of Dunlop Brand
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
With the rise in cannabis legalization, employers face new challenges when it comes to drug testing. Traditional methods such as oral fluid, urine, and hair tests can detect cannabis use for extended periods, ranging from days to months. However, utilizing the Cannabix breathalyzer allows for THC detection in just a few hours after use.
Bill Corl, CEO of Omega Laboratories, emphasized the company's commitment to staying at the forefront of advancements in drug testing technology. He believes that incorporating Cannabix's groundbreaking THC breathalyzer technology will enhance the accuracy, efficiency, and accessibility of cannabis testing.
This strategic partnership between Omega Laboratories and Cannabix Technologies is set to drive innovation and set new standards in cannabis testing, ensuring safer communities and workplaces. For more information on these solutions, interested parties can contact Omega at 1-800-665-5569.
Filed Under: Business
0 Comments
Latest on Ohio Pen
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- Trailhead Biosystems Secures $20 Million to Drive Innovation and Accelerate Growth
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Cogent Communications Faces Federal Scrutiny Over Fraudulent Acquisition and 22-Year Corporate Cover-Up
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Columbus: Clean and Safe Corridors Initiative Takes Place on Sullivant Avenue
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- Psychiatry's Legacy of Racism and Coercion Highlighted in Restraint Deaths
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- Adsposure Announces Winners of Annual Transit Awards
- "Stop scrolling and start watching" - Beloved film recommendation site Criticker gets a major makeover
- Green Energy Solar Expands with New Offices in Port St. Lucie, West Palm Beach, and Orlando